Free guide

Tirzepatide for Weight Management: What to Know

Tirzepatide is a dual GLP-1 and GIP receptor agonist. Zepbound is an FDA-approved tirzepatide product for chronic weight management in eligible adults. Compounded tirzepatide is not Zepbound and availability is subject to clinical and regulatory rules.

Man walking at golden hour, for daily tadalafil and longer-window guides. Tirzepatide for Weight Management: What to Know.
  1. 1

    Read

    Start with the short answer.

  2. 2

    Prepare

    Take a question from the research.

  3. 3

    Speak

    Bring it to a physician.

Feel Ready

For your visit

Speak to a physician

Feel Ready visits are not open yet. These questions are ready for a physician you already see.

Written by Feel Ready Editorial Team

Last updated November 2026

What is tirzepatide?

Tirzepatide activates GLP-1 and GIP pathways involved in appetite and glucose regulation. It is available as FDA-approved Zepbound for chronic weight management when a clinician determines eligibility. Mounjaro is tirzepatide approved for type 2 diabetes—a different labeled use.

Compounded tirzepatide must not be described as Zepbound.

How it differs from semaglutide

Semaglutide and tirzepatide are separate molecules with separate trial data, dosing, and side-effect profiles. One is not universally better; a clinician weighs benefits, risks, access, and cost for each person.

See the semaglutide education page and comparison guides for pricing context.

Compounding and FDA policy

Compounded semaglutide and tirzepatide are not the same products as FDA-approved Ozempic, Wegovy, or Zepbound. Compounding availability depends on patient-specific clinical need and applicable federal and state rules. The FDA has tightened routine compounding of copies now that approved products are commercially available.

Advertised price range

As of November 7, 2026, compounded tirzepatide telehealth offers often start near $248–$299 per month in public ads, with premium providers higher. Manufacturer self-pay Zepbound ads often start near $299. FeelReady's proposed $249 target awaits confirmation.

Common questions

Zepbound is a specific FDA-approved tirzepatide product for chronic weight management. Compounded tirzepatide is not the same labeled product.

Sources

What to ask a physician

These checked public sources are the background for this guide. They do not diagnose you, and they do not tell a physician what to prescribe.

Related guides

Curious about what comes next?

Join the waitlist. When clinician-guided care opens in your state, Feel Ready will contact you about a private consultation. There is no treatment or payment today.

Join the Waitlist